Prosensa's Unattributed - II Round

Prosensa raised a round of funding on December 13, 2011. Investors include Charleys Fund.

Prosensa is a biotechnology company focused on the discovery, development and commercialization of RNA-modulating therapeutics. The company targets genetic disorders with a large unmet medical need, w…

Articles about Prosensa's Unattributed - II Round: